Back
Legal & General Group Plc Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
39
LGGNF
Legal & General Group Plc
Last Price:
$3.47
Seasonality Move:
3.4%
Sell
38
MNPR
Monopar Therapeutics, Inc.
Last Price:
$65.08
Seasonality Move:
9.84%
Sell
39
Legal & General Group Plc (LGGNF)
is a Sell
Is Legal & General Group Plc a Buy, Sell or Hold?
-
The current Legal & General Group Plc [LGGNF] share price is $3.47. The Score for LGGNF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
LGGNF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.30. The Score for MNPR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGGNF Stock Price Chart
What is Legal & General Group Plc's stock price today?
-
The Legal & General Group Plc share price today is $3.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGGNF is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
LGGNF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 56.46 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.31 - 3.45) | Buy |
| Bollinger Bands (100): | (3.17 - 3.43) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.92 | Sell |
| Relative Strength Index (14 RSI): | 34.74 | Sell |
| Chaikin Money Flow: | 193884 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.82 - 81.42) | Sell |
| Bollinger Bands (100): | (48.89 - 89.85) | Sell |
LGGNF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.45 | Buy |
| 20-day SMA: | 3.38 | Buy |
| 50-day SMA: | 3.29 | Buy |
| 200-day SMA: | 3.33 | Buy |
| 8-day EMA: | 3.44 | Buy |
| 20-day EMA: | 3.39 | Buy |
| 50-day EMA: | 3.29 | Buy |
| 200-day EMA: | 2.19 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.19 | Sell |
| 20-day SMA: | 72.23 | Sell |
| 50-day SMA: | 78.7 | Sell |
| 200-day SMA: | 53.66 | Buy |
| 8-day EMA: | 67.77 | Sell |
| 20-day EMA: | 71.75 | Sell |
| 50-day EMA: | 74.63 | Sell |
| 200-day EMA: | 57.45 | Buy |
Legal & General Group Plc Earnings Growth & LGGNF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.34 per share.
Legal & General Group Plc Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||